"The profound and devastating side effects of certain Parkinson’s medications, particularly dopamine agonists, are tearing families apart, leaving a trail of financial ruin, shattered reputations, and even tragic loss of life, often without adequate warnings or systemic recognition of the full scope of their impact."
The tragic saga of Andrew, a respected solicitor whose life spiraled into fraud and ultimately suicide, serves as a stark illustration of a widespread, yet often unacknowledged, public health crisis. His story, rooted in impulsive behaviors triggered by medication prescribed for Parkinson’s disease, exposes a critical gap in patient care and regulatory oversight, where the hidden costs of these powerful drugs extend far beyond the individual patient, devastating entire families and communities. This investigation reveals how a family of medications, while offering relief for debilitating conditions, can inadvertently unleash destructive compulsions, transforming ordinary lives into nightmares of addiction, debt, and profound loss, all while official warnings remain insufficient and the full human toll goes largely unrecorded.
For Frances, the morning started like any other, until a phone call shattered her reality. Police officers had arrested her husband, Andrew, a trusted solicitor, on allegations of defrauding clients. Their family home, shared with their two children, was being searched, and Andrew’s office in a tranquil village south of Manchester was sealed off with yellow crime tape, staff reeling in disbelief as records were meticulously packed away. The scene was one of utter chaos and disbelief, a sudden intrusion of law enforcement into what had been a seemingly ordinary, respectable life.
Andrew’s legal practice managed the affairs of many vulnerable elderly clients, some suffering from dementia, holding their power of attorney. The police investigation quickly unearthed a shocking discovery: hundreds of thousands of pounds entrusted to Andrew were missing from these clients’ accounts. Further scrutiny revealed the funds had been squandered on a secret life of adult webcam sites, sex workers, and compulsive antique purchases. This revelation was not only scandalous but deeply perplexing, completely at odds with the character of the man Frances knew.
The subsequent court proceedings would unravel a complex narrative, pointing to a harrowing truth: Andrew’s uncharacteristic and impulsive behavior was attributed to the medication he was prescribed for Parkinson’s disease, specifically a class of drugs known as dopamine agonists. He had stolen from 13 clients, 11 of whom were over 80 and many in poor health, collectively siphoning approximately £600,000 from their life savings. The consequences were dire and immediate for some victims. One 87-year-old, residing in a care home, passed away shortly after the theft, her estate so depleted that there wasn’t enough money left to cover her funeral expenses, a profoundly cruel injustice.
"People didn’t want to know us, and I can understand that entirely," Frances reflected, grappling with the devastating fallout of Andrew’s actions. Their daughter, Alice, added that her father "never forgave himself," hinting at the immense internal torment Andrew endured. This insidious change in behavior, fueled by medication, would ultimately lead to tragic and irreversible consequences for Andrew and his family.
Andrew’s case, while extreme in its scope, is far from an isolated incident. Over the past year, investigations have uncovered countless families whose lives have been irrevocably damaged by impulsive behaviors directly linked to dopamine agonist drugs. These powerful medications, while vital for treating conditions like Parkinson’s and Restless Legs Syndrome, are associated with the development of severe Impulse Control Disorders (ICDs). The range of these disorders is broad and destructive, encompassing new and intense sexual urges, such as addictions to pornography and sex workers, as well as compulsive shopping, gambling, and overeating. These behaviors frequently result in individuals losing tens or even hundreds of thousands of pounds, wiping out life savings and destroying financial stability.
Dopamine agonists function by mimicking the effects of dopamine, a neurotransmitter that plays a crucial role in regulating movement, motivation, and reward in the brain. For Parkinson’s patients, who experience a depletion of dopamine-producing neurons, these drugs can be life-changing, significantly improving motor symptoms. However, by stimulating dopamine pathways excessively, especially those linked to reward, they can inadvertently trigger compulsive behaviors in susceptible individuals. These drugs are widely prescribed, with GPs in England alone issuing over 1.5 million prescriptions in the past year. Current NHS advice rightly urges anyone with concerns about these medications to consult their doctor immediately. A significant 2010 study of over 3,000 Parkinson’s patients revealed that approximately one in six individuals taking dopamine agonists develop impulse control disorders, underscoring the prevalence of this alarming side effect.
In response to these findings, the chair of the MPs’ Health Select Committee has voiced profound concern, describing the investigation’s revelations as "devastating" and formally requesting the UK drugs regulator to reassess and bolster official warnings. A recurring theme among those affected is the complete absence of any prior history of such impulsive behaviors before commencing the medication. Many recount making no connection between their emerging compulsions and their prescribed drugs, often for years. This lack of awareness is compounded by what many describe as a critical failure by medical professionals to adequately warn them about these potential side effects or to properly monitor for their onset.
Back in the summer of 2013, in the immediate aftermath of his arrest, Andrew made a valiant attempt to maintain a facade of normalcy for his family. However, the immense stress and shame proved too much. That Sunday, he collapsed at home and was rushed to A&E. He had been diagnosed with Parkinson’s several years prior, and when his tremors began to worsen, he was prescribed Pramipexole, a dopamine agonist. Frances described the medication’s initial effects as nothing short of "miraculous." Andrew’s debilitating tremors dramatically subsided, and he even returned to playing tennis, enjoying a renewed sense of physical freedom.
It was in the A&E department, during a conversation with a doctor, that Frances first heard the chilling truth: Pramipexole could induce a range of impulsive behaviors. The revelation was a "terrible shock," she recalled, unable to comprehend why this critical information had never been shared with her, despite her consistent presence at all of Andrew’s appointments. The potential side effects, suddenly brought to light, provided a stark and terrifying explanation for Andrew’s increasingly erratic and compulsive shopping habits, though at that point, she still had no grasp of the true, catastrophic scale of his illicit spending.
Before his Parkinson’s diagnosis and subsequent medication, Andrew’s engagement with webcams and sex-chat sites was infrequent, perhaps once a week. However, in the year following the initiation of Pramipexole, his activity surged dramatically, with nearly 500 payments made to these platforms. The investigation would later uncover that he spent over £100,000 on a single website using his clients’ money. In an astonishing four-month period, he also spent nearly £80,000 on sex workers, and upon his arrest, his mobile phone contained the contact details of 90 different escorts. Beyond sexual compulsions, Andrew, a lifelong history enthusiast, developed an insatiable urge to acquire antique pens, pottery, and cricket memorabilia, spending £85,000 on eBay in the six months leading up to the police raid. "Dad was so ashamed from the point he was arrested, he basically didn’t leave the house," Alice recounted, highlighting his profound withdrawal and self-imposed isolation.
For over a year, the family endured an agonizing wait for prosecutors to decide on charges. Eventually, Andrew was charged with fraud. The unfolding legal drama further exacerbated the family’s pain, particularly for their son, Harry, who had long struggled with mental health issues. Harry "loved his dad very much," Frances explained, but the trauma of his father’s arrest and subsequent public disgrace proved "very difficult to cope with." Harry’s mental health deteriorated to the point where he was sectioned. After returning home, he disappeared, and weeks later, his body was discovered. He had taken his own life, a devastating collateral casualty of the medication’s unseen ripple effects.
In 2015, Andrew pleaded guilty in court. During sentencing, Mr. Justice Openshaw acknowledged the compelling evidence that Andrew’s behavior was a direct consequence of the drugs he was taking, citing his squandering of clients’ money on "sexual excesses" and "absurd extravagances." However, the judge also maintained that Andrew, as a practicing solicitor, retained sufficient cognitive capacity to competently conduct other aspects of his business. He argued that Andrew, with his network of family, friends, and professional advisors, should have recognized the medication’s impact and sought help. Andrew was sentenced to four years in HM Prison Manchester, famously known as Strangeways.
During the lengthy investigation and legal proceedings, all of Andrew’s assets were frozen to facilitate the recouping of funds stolen from his clients. Furthermore, the family faced insurmountable legal hurdles in pursuing a clinical negligence case against Andrew’s doctors. Legal rules often preclude the recovery of damages closely connected to serious criminal acts, effectively blocking a path to justice for the systemic failures in his care.
Frances and Andrew divorced while he was incarcerated. Upon his release after serving two years of his sentence, Andrew moved into sheltered accommodation. The ordeal of prison, compounded by the isolation of the Covid lockdowns, had taken a severe toll on his physical and mental health. He had ceased taking the dopamine agonist medication immediately upon realizing its devastating effects, leading to a significant and rapid progression of his Parkinson’s symptoms. "I think his whole life got completely dismantled," Alice reflected, attributing the profound unraveling not just to Parkinson’s, but fundamentally to the drugs. In October 2020, Andrew tragically took his own life.
Crucially, Andrew’s death is not recorded in the UK’s Yellow Card public record, the MHRA (Medicines and Healthcare products Regulatory Agency) scheme that collates reported adverse effects of drugs. Nor will it include the death of his son, Harry. This glaring omission highlights a critical flaw in the current reporting system: the collateral harm inflicted by dopamine agonist drugs on wider families, including mental health crises, financial ruin, and even suicide, remains largely unrecorded. Many families, like Andrew’s, have lost their life savings or even their homes due to users’ compulsive gambling, shopping, or other destructive behaviors. They are frequently left without any recourse to justice for their losses, hampered by the complexities of mounting class actions in the UK and the formidable challenges of proving clinical negligence, which often requires demonstrating a clear failure to warn.
The link between dopamine agonist drugs and impulsive behavior has been scientifically established for more than two decades. Last year, the BBC revealed that GSK, the British pharmaceutical giant that first licensed this class of drug for Parkinson’s in the UK, had discovered a connection between its medication and what it termed "deviant" sexual behavior as far back as 2003. Warnings did appear three years later, in 2006, but these were vague, listing only the potential for an "increased libido," "harmful behavior," and an "altered sexual interest." Even today, patient information leaflets fail to state how common impulse control disorders truly are, leaving patients and their families woefully uninformed.
Layla Moran, the Liberal Democrat MP and chair of the MPs’ Health Select Committee, is now spearheading calls for a significant overhaul of these warnings. She argues that the information provided to patients must explicitly detail the overall prevalence of impulse control disorders and specify the diverse range of behaviors that can emerge, such as pornography addiction. "It’s not just a side effect that affects an individual, it’s affecting families and communities and creating new victims," Moran asserted. "What does ‘impulsive behavior’ mean and how likely is it that they [patients] can get it? At the moment, patients don’t have that information, and without it, how can they be expected to mitigate it?" Moran has also criticized the MHRA’s Yellow Card scheme as "not fit for purpose" for reporting side effects that individuals find deeply shameful, leading to significant underreporting.
The government has acknowledged the findings as "hugely concerning." However, the MHRA maintains there are no immediate plans to alter the existing warnings. The agency contends that these sexual behaviors are "individualized," making it impossible to include an "exhaustive list" in information leaflets. It previously told the BBC that it does not list the frequency of impulse control disorders because many people do not report them, creating a circular problem that perpetuates the lack of transparency. GSK has defended its drug, stating it has undergone extensive trials, received repeated regulatory approvals worldwide, and has been prescribed for over 17 million treatments. The company also confirmed it had shared its safety reports with regulators. Boehringer Ingelheim, the manufacturer of Andrew’s prescribed drug, Pramipexole, declined to comment on the investigation’s findings.
In 2017, the National Institute for Health and Care Excellence (NICE) issued guidelines requiring doctors to provide Parkinson’s patients and their families with both verbal and written information about the risk of impulsive behaviors, alongside regular monitoring for their development. Yet, the BBC has heard from numerous Parkinson’s patients prescribed these drugs since the guidelines were introduced who attest they were never properly warned about the risks. Many continue to suffer from these debilitating impulsive behaviors today, highlighting a persistent gap between official guidelines and actual clinical practice.
Alice and Frances have since moved hundreds of miles away from their former village, seeking a fresh start, but the profound pain of their experiences endures. "I had my life taken away from me: my home, the community I lived in, but above all my son," Frances lamented, her voice heavy with grief. "I just don’t have the words to say how devastating that is." Their story stands as a powerful testament to the urgent need for enhanced awareness, improved patient warnings, and a more robust system of accountability for the devastating side effects of dopamine agonist drugs.
If you have been affected by the issues raised in this story you can visit the BBC Action Line for support.